SK Capital Partners has announced it has closed its latest fund with $800 million in commitments.
The new fund, SKCP Catalyst Fund II, was oversubscribed. It will focus on buyout investments that generally require initial committed equity capital of up to $100 million.
SK Capital Partners, based in New York, is a private equity firm focused on the life sciences and a few other sectors. The firm typically pursues control buyouts, recapitalizations and growth equity investments.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
